Striving for better kidney health

The Renal Clinician

Recent Blog Articles

Interpreting Hypocitraturia: An Etiology First Approach

As a nephrologist, I frequently see patients with kidney stones, and one finding that appears with striking regularity on metabolic evaluations is hypocitraturia, defined as urine citrate <320 mg/day. In large-scale urine studies, hypocitraturia is now the third most common metabolic abnormality in stone formers, surpassed only by high urine calcium (>250mg/day) and low urine volume (< 2 L/day), significant risk factors for kidney stone formation (1). Over the past two decade

Metabolic Bone Diseases

Viresh Mohanlal, MD

Nov 11, 20254 min read

Rethinking Osteoporosis in Chronic Kidney Disease: Breaking Norms, Saving Bones (Part 1)

Chronic Kidney Disease—Mineral Bone Disease (CKD-MBD) encompasses a spectrum of skeletal, vascular, and mineral metabolism abnormalities,...

Metabolic Bone Diseases

Viresh Mohanlal, MD

May 17, 20255 min read

Hyponatremia Due to Reset Osmostat: Uncovering the Clues

Hyponatremia, a condition affecting 1 in 3 hospitalized adult patients, is a prevalent and significant electrolyte abnormality (1). It is...

Electrolyte and Acid Base Disorders

Viresh Mohanlal, MD

Apr 23, 20254 min read

Picture Perfect
One shot says it all

Target Antigens in membranous Nephropathy

Heat Map for CKD progression

Risk of progression of CKD to ESRD based on GFR and albuminuria criteria.

Anti Nephrin Antibodies

The diffuse punctate staining (dusting) seen with anti nephrin IgG antibody in subset of patients with minimal change disease.

Target Antigens in membranous Nephropathy

1/4

Our Mission

The Renal Clinician's mission is to cultivate a community of physicians who share clinical insights and best practices for optimizing patient care and advancing kidney health. Through this blog, we would like to share the knowledge and experiences gained from daily patient care in hospitals, dialysis centers, and clinics, enriching the practice of fellow nephrologists and internists and advancing patient outcomes.